perfosfamide has been researched along with Multiple Myeloma in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (37.50) | 18.7374 |
| 1990's | 3 (37.50) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akutsu, M; Furukawa, Y; Hiraoka, N; Kano, Y; Kikuchi, J; Koyama, D; Mori, S; Nakamura, Y; Ueda, T; Uesawa, M; Wada, T; Yamauchi, T | 1 |
| Barnett, MJ; Connors, JM; Klingemann, HG; O'Reilly, SE; Phillips, GL; Reece, DE; Shepherd, JD; Sutherland, HJ | 1 |
| Griffin, CA; Piantadosi, S; Rowley, S; Santos, G; Shah, NK; Wingard, JR | 1 |
| Barnett, MJ; Brockington, DA; Klingemann, HG; Nantel, SH; Phillips, GL; Reece, DE; Shepherd, JD; Sutherland, HJ | 1 |
| Clarkson, BD; Fried, J; Fujita, N; Gulati, SC; Inaba, T; Murakami, S; Nakagawa, M; Shimazaki, C; Wang, CY; Wisniewolski, R | 1 |
| Atzpodien, J; Clarkson, BD; Gulati, SC; Lemoli, RM; Shimazaki, C | 1 |
| Atzpodien, J; Clarkson, BD; Colvin, OM; Fried, J; Gulati, SC; Shimazaki, C | 1 |
| Colvin, OM; Frondoza, CG; Humphrey, RL; Sinha, S; Trivedi, SM | 1 |
2 trial(s) available for perfosfamide and Multiple Myeloma
| Article | Year |
|---|---|
Treatment of multiple myeloma with intensive chemotherapy followed by autologous BMT using marrow purged with 4-hydroperoxycyclophosphamide.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Purging; Bone Marrow Transplantation; Busulfan; Clinical Protocols; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dexamethasone; Female; Humans; Life Tables; Male; Melphalan; Middle Aged; Multiple Myeloma; Survival Analysis; Transplantation, Autologous; Vincristine | 1993 |
Prolonged survival after intensive therapy and purged ABMT in patients with multiple myeloma.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Purging; Bone Marrow Transplantation; Combined Modality Therapy; Cyclophosphamide; Dexamethasone; Disease-Free Survival; Doxorubicin; Female; Humans; Interferon-alpha; Male; Middle Aged; Multiple Myeloma; Treatment Outcome; Vincristine | 2000 |
6 other study(ies) available for perfosfamide and Multiple Myeloma
| Article | Year |
|---|---|
Purine analog-like properties of bendamustine underlie rapid activation of DNA damage response and synergistic effects with pyrimidine analogues in lymphoid malignancies.
Topics: Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cyclophosphamide; Cytarabine; DNA Damage; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Drug Synergism; Humans; Inhibitory Concentration 50; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Mantle-Cell; Multiple Myeloma; Pyrimidines; Rituximab | 2014 |
Chromosome abnormalities in patients treated with 4-hydroperoxycyclophosphamide-purged autologous bone marrow transplantation.
Topics: Adolescent; Adult; Bone Marrow Purging; Child; Child, Preschool; Chromosome Aberrations; Chromosome Disorders; Cyclophosphamide; Female; Hodgkin Disease; Humans; Karyotyping; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Male; Middle Aged; Multiple Myeloma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Translocation, Genetic | 1993 |
Purging of myeloma cells from bone marrow using monoclonal antibodies and magnetic immunobeads in combination with 4-hydroperoxycyclophosphamide.
Topics: Antibodies, Monoclonal; Antigens, Neoplasm; Bone Marrow; Bone Marrow Cells; Colony-Forming Units Assay; Combined Modality Therapy; Cyclophosphamide; Etoposide; Humans; Magnetics; Microspheres; Multiple Myeloma; Tumor Cells, Cultured; Tumor Stem Cell Assay | 1990 |
Ex vivo treatment of myeloma cells by 4-HC, VP-16, LAK cells and antibodies.
Topics: Antibodies, Monoclonal; Cell Separation; Colony-Forming Units Assay; Cyclophosphamide; Cytotoxicity, Immunologic; Etoposide; Hematopoietic Stem Cells; Humans; Killer Cells, Natural; Magnetics; Multiple Myeloma; Tumor Cells, Cultured; Tumor Stem Cell Assay | 1989 |
Ex vivo treatment of myeloma cells by 4-hydroperoxycyclophosphamide and VP-16-213.
Topics: Bone Marrow; Cell Communication; Cell Line; Cell Survival; Colony-Forming Units Assay; Cyclophosphamide; Hematopoiesis; Humans; Multiple Myeloma; Neoplastic Stem Cells; Podophyllotoxin | 1988 |
Detection of residual murine LPC-1 myeloma cells from bone marrow cell mixture after purging by 4-hydroperoxycyclophosphamide.
Topics: Animals; Antigens, Neoplasm; Antineoplastic Agents; Bone Marrow; Bone Marrow Cells; Bone Marrow Transplantation; Cell Line; Cyclophosphamide; Cytotoxicity, Immunologic; Female; Growth; Mice; Mice, Inbred BALB C; Multiple Myeloma; Neoplastic Stem Cells; Tumor Stem Cell Assay | 1987 |